INOGEN INC (INGN) Stock Price, Quote, News and Overview
NASDAQ:INGN - Nasdaq - US45780L1044 - Common Stock - Currency: USD
INGN Quote, Performance and Key Statistics
6.53
0 (0%)
The current stock price of INGN is 6.53 USD. In the past month the price decreased by -8.42%. In the past year, price decreased by -21.33%.
INGN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.79 | 231.14B | ||
| ISRG | INTUITIVE SURGICAL INC | 72.74 | 199.19B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.7 | 154.60B | ||
| SYK | STRYKER CORP | 30.51 | 146.12B | ||
| MDT | MEDTRONIC PLC | 14.98 | 105.69B | ||
| BDX | BECTON DICKINSON AND CO | 12.34 | 49.82B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.9 | 45.60B | ||
| IDXX | IDEXX LABORATORIES INC | 45.22 | 41.78B | ||
| RMD | RESMED INC | 27 | 35.94B | ||
| DXCM | DEXCOM INC | 51.43 | 33.27B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.55 | 32.75B | ||
| STE | STERIS PLC | 26.23 | 24.07B |
Related stock screener links
About INGN
Company Profile
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 766 full-time employees. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.
Company Info
INOGEN INC
859 Ward Drive
Goleta CALIFORNIA 93117 US
CEO: Nabil Shabshab
Employees: 766
Phone: 18055620500
INOGEN INC / INGN FAQ
What is the stock price of INOGEN INC today?
The current stock price of INGN is 6.53 USD.
What is the ticker symbol for INOGEN INC stock?
The exchange symbol of INOGEN INC is INGN and it is listed on the Nasdaq exchange.
On which exchange is INGN stock listed?
INGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INOGEN INC stock?
9 analysts have analysed INGN and the average price target is 10.2 USD. This implies a price increase of 56.2% is expected in the next year compared to the current price of 6.53. Check the INOGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INOGEN INC worth?
INOGEN INC (INGN) has a market capitalization of 175.59M USD. This makes INGN a Micro Cap stock.
How many employees does INOGEN INC have?
INOGEN INC (INGN) currently has 766 employees.
What are the support and resistance levels for INOGEN INC (INGN) stock?
INOGEN INC (INGN) has a support level at 6.51 and a resistance level at 7.18. Check the full technical report for a detailed analysis of INGN support and resistance levels.
Is INOGEN INC (INGN) expected to grow?
The Revenue of INOGEN INC (INGN) is expected to grow by 7.2% in the next year. Check the estimates tab for more information on the INGN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INOGEN INC (INGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of INGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of INGN, evaluating the profitability, health, valuation and growth aspects
- INOGEN INC (INGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INOGEN INC (INGN) Sales and EPS estimates to see what analysts future expectations are.
- INOGEN INC (INGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INOGEN INC (INGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- INOGEN INC (INGN) Stock Chart to make your own analysis
- INOGEN INC (INGN) Latest news and press-releases to stay up to date.
Does INOGEN INC (INGN) stock pay dividends?
INGN does not pay a dividend.
When does INOGEN INC (INGN) report earnings?
INOGEN INC (INGN) will report earnings on 2025-08-04, after the market close.
What is the Price/Earnings (PE) ratio of INOGEN INC (INGN)?
INOGEN INC (INGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.15).
What is the Short Interest ratio of INOGEN INC (INGN) stock?
The outstanding short interest for INOGEN INC (INGN) is 4.33% of its float. Check the ownership tab for more information on the INGN short interest.
INGN Technical Analysis
INGN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to INGN. INGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
INGN Financial Highlights
Over the last trailing twelve months INGN reported a non-GAAP Earnings per Share(EPS) of -1.15. The EPS increased by 57.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.12% | ||
| ROE | -20.64% | ||
| Debt/Equity | 0 |
INGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 51% to INGN. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 25.18% and a revenue growth 7.2% for INGN